Denver, CO (PRWEB) September 22, 2008
LegalView.com, the number one resource for everything and anything legal on the Web, recently reported a U.S. Food and Drug Administration (FDA) investigation that was launched to determine the alleged risks of cancer among a group of immune suppressors including Cimzia. The family of drugs known as TNF blockers, which include Cimzia (certolizumab pegol), Enbrel (etanercept), Humira (adalimumab) and Remicade (infliximab), had reportedly been causing severe and fatal reactions among patients and may be linked to an increased risk of cancer among younger patients, including children. Individuals who have taken Cimzia and who have suffered any Cimzia side effects should consider contacting a medical professional immediately. Additionally, locating an experienced pharmaceutical lawyer, who can provide information regarding a potential Cimzia class action lawsuit, is advised.
Cimzia, along with the other TNF blockers, are used to treat autoimmune disorders such as rheumatoid arthritis, Crohn's disease, plaque psoriasis and ulcerative colitis, according to a Reuter's article. The FDA's investigation into the drugs occurred after 30 cases were reported of cancer having appeared among patients, specifically young adults and children, after having taken the drugs. If a family member has taken any of the drugs it may be important to contact an experienced Cimzia attorney to discuss the details of developing a Cimzia case to deal with any potential damages that may have occurred.
In addition to information on the Cimzia risks, LegalView offers a full library of pharmaceutical drugs that may also be causing severe harm to patients. Some of the most recent information portals that have been launched to provide patients with the most up-to-date information include Byetta, Ketek and Cipro.
Byetta, similar to Avandia, is a type 2 diabetes drug that is used to control the levels of glucose in individuals. The drug, from makers Amylin Pharmaceuticals and Eli Lilly, is injectable and provides a patient with insulin. However, the drug was recently linked to the development of pancreatitis among patients. The FDA also said the drug may be allegedly responsible for up to six patient deaths. If you are taking Byetta and are concerned about the potential for developing any of the Byetta risks, speak to a medical professional immediately.
Both Ketek and Cipro are antibiotics that treat bacterial infections, and the two have both been in the news for an array of dangerous side effects. Ketek (Telithromycin), which is manufactured by Sanofi-Aventis, is being investigated because of nearly 100 reports from Ketek patients that the drug's side effects were causing liver damage. An additional 18 reports of the Ketek dangers were allegedly said to have caused the fatalities of several patients.
Cipro, on the other hand, is part of the fluoroquinolone drug family, which was recently given the black box labeling by the FDA. A black box warning label is among the harshest labels given to a prescription drug by the FDA. The FDA reportedly uncovered an extreme risk of tendonitis among the fluoroquinolone drug family. The fluoroquinolone drug family consists of Cipro (ciprofloaxacin), Levaquin (levofloxacin), Factive (gemifloxacin mesylate), Avelox (moxifloxacin HCL), Cipro XR and Proquin XR (ciprofloaxacin extended release), Noroxin (norfloxacin) and Floxin (ofloxacin). To learn more about the Cipro side affects, it may be advisable to contact a Cipro lawyer.
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.LegalView.com/.